Cancer in many ways has become the #1 health priority in the United States both in terms of cost and impact on patient's lives. Fortunately, many throughout the world are developing new techniques to gain better understanding of cancer and to develop more effective therapeutics. Currently, oncologists who treat cancer use various staining techniques and microscopes to visualize unique aspects of the tumor. Now, with sequencing technology, oncologists can unravel deeper understanding of the tumor's biology.
Conventional tumor staining
Tumors that arise in patients and progress are driven by gene mutations that coalesce into specific pathways and networks. By identifying and targeting these critical pathways or networks, there is hope that breakthroughs in cancer treatments can be acheived. For example, below depicts one such pathway.
A vast pipeline of drugs are being developed by different companies that are becoming readily available for oncologists to prescribe for individual use. It is estimated that there are nearly 1000 new drug compounds in development for cancer therapy.
Targeted drug therapy
Genection hopes to accelerate and streamline this process for all.